Product Code: ETC8849976 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
With a rising number of psoriasis patients, the psoriatic arthritis treatment market in the Philippines is also expanding. The market is driven by increasing healthcare expenditure, the availability of disease-modifying antirheumatic drugs (DMARDs), and targeted biologic therapies. While conventional nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids are still commonly prescribed, newer treatment options such as JAK inhibitors and TNF-alpha inhibitors are gaining traction due to their long-term efficacy.
The rising incidence of psoriatic arthritis in the Philippines is fueling the demand for effective treatment options, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologic agents. As awareness of the link between psoriasis and arthritis increases, more patients are seeking early diagnosis and treatment. The market is benefiting from expanding healthcare infrastructure and the availability of advanced biologic therapies, though affordability and access to specialized care remain barriers to widespread treatment adoption.
Managing psoriatic arthritis in the Philippines is complicated by the high cost of targeted therapies, making them inaccessible to many patients. The availability of rheumatologists is limited, particularly outside major urban centers, leading to delayed diagnosis and treatment. Moreover, awareness about psoriatic arthritis remains low, resulting in underdiagnosis and mismanagement, which worsens disease outcomes.
The market for psoriatic arthritis treatment in the Philippines is expanding as more patients seek early diagnosis and effective management of the disease. With growing investments in immunosuppressants and biologic drugs, the availability of treatment options is improving. Pharmaceutical companies are focusing on expanding access through strategic partnerships with healthcare institutions. The increasing acceptance of combination therapies and targeted biologics presents significant investment opportunities, particularly in specialty clinics and telemedicine platforms for chronic disease management.
The Philippine government has been making efforts to enhance access to psoriatic arthritis treatments through its universal healthcare initiatives. While PhilHealth provides partial coverage for some treatments, access to biologics and advanced therapies remains costly. The Department of Health (DOH) collaborates with medical organizations to improve awareness and early diagnosis. Regulatory approvals for new medications go through the Food and Drug Administration (FDA), ensuring patient safety. However, the lack of specialized rheumatology centers in rural areas continues to limit healthcare accessibility for many Filipinos.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Psoriatic Arthritis Treatment Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Psoriatic Arthritis Treatment Market - Industry Life Cycle |
3.4 Philippines Psoriatic Arthritis Treatment Market - Porter's Five Forces |
3.5 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Psoriatic Arthritis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Psoriatic Arthritis Treatment Market Trends |
6 Philippines Psoriatic Arthritis Treatment Market, By Types |
6.1 Philippines Psoriatic Arthritis Treatment Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Non-steroidal Anti-inflammatory Drugs (NSAIDs), 2021- 2031F |
6.1.4 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Disease-modifying Antirheumatic Drugs (DMARDs), 2021- 2031F |
6.1.5 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Biologics, 2021- 2031F |
6.2 Philippines Psoriatic Arthritis Treatment Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Oligoarticular, 2021- 2031F |
6.2.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Polyarticular, 2021- 2031F |
6.3 Philippines Psoriatic Arthritis Treatment Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Therapy, 2021- 2031F |
6.3.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.4 Philippines Psoriatic Arthritis Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 Philippines Psoriatic Arthritis Treatment Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 Philippines Psoriatic Arthritis Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Philippines Psoriatic Arthritis Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Philippines Psoriatic Arthritis Treatment Market Import-Export Trade Statistics |
7.1 Philippines Psoriatic Arthritis Treatment Market Export to Major Countries |
7.2 Philippines Psoriatic Arthritis Treatment Market Imports from Major Countries |
8 Philippines Psoriatic Arthritis Treatment Market Key Performance Indicators |
9 Philippines Psoriatic Arthritis Treatment Market - Opportunity Assessment |
9.1 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Philippines Psoriatic Arthritis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Psoriatic Arthritis Treatment Market - Competitive Landscape |
10.1 Philippines Psoriatic Arthritis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Philippines Psoriatic Arthritis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |